Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.89 |
| ▸ | RECQL | P46063 | 2/20 | 0.89 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.89 |
| ▸ | TSHR | P16473 | 3/20 | 0.74 |
| ▸ | HCAR2 | Q8TDS4 | 8/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.36 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.36 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bixin SCHEMBL42729 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| Bixin SCHEMBL9939959 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| Bixin SCHEMBL29939591 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| SCHEMBL30873767 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| SCHEMBL1463087 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| SCHEMBL30404058 | 0.92 | ALDH1A1 (0.85) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| Bixin SCHEMBL3287610 | 0.91 | ALDH1A1 (0.82) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| Bixin SCHEMBL22344763 | 0.91 | ALDH1A1 (0.82) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| SCHEMBL25460630 | 0.87 | ALDH1A1 (0.77) | ALDH1A1MAPTTDP1KDM4EALOX15 | |
| SCHEMBL29378795 | 0.87 | ALDH1A1 (0.77) | ALDH1A1MAPTTDP1KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564552-B2 | Oral product with a basic amine and an ion pairing agent | Nicoventures Trading Limited (GB) | 2026-03-03 | — | — | US | disclosed |
| EP-4687501-A1 | EMULSIONS FOR NICOTINE ENCAPSULATION | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4687504-A1 | ORAL COMPOSITIONS AND METHODS OF MANUFACTURE | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4687503-A1 | FUNCTIONALIZED FLEECE MATERIAL PRODUCTION | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4687502-A1 | STARCHLESS MOLDING PROCESS FOR ORAL PRODUCTS | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4678009-A1 | PREMIX CONTAINING GELLING AGENT FOR ORAL PRODUCT | Nicoventures Trading Limited (GB) | 2026-01-14 | — | — | EP | disclosed |
| EP-4665172-A1 | ORAL PRODUCTS WITH HIGH-DENSITY LOAD | Nicoventures Trading Limited (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-4659595-A1 | NICOTINE-POLYMER COMPLEX COMPRISING MULTIPLE NICOTINE FORMS | Nicoventures Trading Limited (GB) | 2025-12-10 | — | — | EP | disclosed |
| EP-4659596-A1 | ORAL PRODUCTS WITH LOW FREE-BASE NICOTINE CONTENT | Nicoventures Trading Limited (GB) | 2025-12-10 | — | — | EP | disclosed |
| EP-4659594-A1 | ORAL PRODUCTS CONTAINING MODIFIED NICOTINE-POLYMER COMPLEX | Nicoventures Trading Limited (GB) | 2025-12-10 | — | — | EP | disclosed |
| US-20220369688-A1 | ORAL COMPOSITIONS AND RELATED METHODS FOR REDUCING THROAT IRRITATION | NICOVENTURES TRADING LTD (GB) | 2022-11-24 | — | — | US | disclosed |
| US-20220354785-A1 | ORAL LOZENGE PRODUCTS | NICOVENTURES TRADING LTD (GB) | 2022-11-10 | — | — | US | disclosed |
| US-20220354155-A1 | MULTI-COMPARTMENT ORAL POUCHED PRODUCT | NICOVENTURES TRADING LTD (GB) | 2022-11-10 | — | — | US | disclosed |
| US-20220354156-A1 | ORAL POUCHED PRODUCT WITH HIGH DENSITY LOAD | NICOVENTURES TRADING LTD (GB) | 2022-11-10 | — | — | US | disclosed |
| US-20220347165-A1 | EFFERVESCENT ORAL COMPOSITION | NICOVENTURES TRADING LTD (GB) | 2022-11-03 | — | — | US | disclosed |
| US-20220346434-A1 | ORAL COMPOSITIONS AND METHODS OF MANUFACTURE | NICOVENTURES TRADING LTD (GB) | 2022-11-03 | — | — | US | disclosed |
| WO-2022229926-A1 | MULTI-COMPARTMENT ORAL POUCHED PRODUCT | Nicoventures Trading Limited (GB) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022229929-A1 | ORAL PRODUCTS WITH HIGH-DENSITY LOAD | Nicoventures Trading Limited (GB) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022224196-A1 | ORALLY DISSOLVING FILMS | Nicoventures Trading Limited (GB) | 2022-10-27 | — | — | WO | disclosed |
| WO-2022224197-A1 | EFFERVESCENT ORAL COMPOSITION | Nicoventures Trading Limited (GB) | 2022-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220346434-A1 | ORAL COMPOSITIONS AND METHODS OF MANUFACTURE | OR10J3, OTC, ALG3 | ALDH1A1 936/4885MAPT 495/4885TDP1 2200/4885 |
| US-20220369688-A1 | ORAL COMPOSITIONS AND RELATED METHODS FOR REDUCING THROAT IRRITATION | SLC22A8, SLCO4C1, SLCO2A1 | ALDH1A1 2237/4885MAPT 2437/4885TDP1 838/4885 |
| US-12564552-B2 | Oral product with a basic amine and an ion pairing agent | SLC25A11, SLC16A7, SDHB | ALDH1A1 524/4885MAPT 671/4885TDP1 2734/4885 |
| US-20220354155-A1 | MULTI-COMPARTMENT ORAL POUCHED PRODUCT | TAS2R20, TAS2R5, TAS2R10 | ALDH1A1 1366/4885MAPT 4734/4885TDP1 2284/4885 |
| US-20220354785-A1 | ORAL LOZENGE PRODUCTS | OTC, OSGEP, OLA1 | ALDH1A1 1037/4885MAPT 3174/4885TDP1 3077/4885 |
| US-20220347165-A1 | EFFERVESCENT ORAL COMPOSITION | TAS2R40, TAS2R60, SOST | ALDH1A1 2393/4885MAPT 1803/4885TDP1 2736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.